The market is pricing Dave & Buster's (NASDAQ:PLAY) as an equity sliver on top of a large debt stack, and shorts are positioned for a covenant squeeze. The shares fell 0.63% on October 16, 2026, and no company-specific catalyst was identified in the filings …
The market is trading Novavax (NASDAQ:NVAX) as a lottery ticket on outbreak headlines, even though the company has no plague vaccine. The shares rose 20.08% on October 5, 2026 as short sellers covered, and fell 12% on October 6 when the World Health Organization …
The market is deciding whether Bitdeer (NASDAQ:BTDR) is a Bitcoin (BTC) miner burning cash or an AI infrastructure landlord with contracted revenue, and shorts are betting on the first. The shares rose 0.48% on October 16, 2026, and no company-specific catalyst was identified in …
The market is paying USD 1.02 billion for a company that reported USD 569,925 of quarterly revenue, and a quarter of the float is borrowed and sold. Annualised revenue of USD 2.28 million puts the table market capitalisation at 447 times sales (own arithmetic). …
One share in four is sold short ahead of a binary data event. Days to cover is shares short divided by average daily volume, and 12.5 implies average volume of 3.56 million shares (own arithmetic). At USD 22.66 the short position is worth USD …
The stake is a USD 322 million market value resting on USD 3.66 million of trailing revenue. TJGC Group (NASDAQ:TJGC) leads because 611.83% less a 3.98% benchmark gain leaves a relative strength reading of 607.85 (own arithmetic; the benchmark return is implied by the …
The market is paying for cancer revenue the company does not yet earn. Moderna (NASDAQ:MRNA) holds the top three-month relative strength at 241.19 (the 245.17% raw gain less a 3.98% benchmark gain, own arithmetic). The catalyst was the August 19, 2026 announcement that intismeran …
The tension is a one-month surge with no identified cause. 5E Advanced Materials (NASDAQ:FEAM) earned 84.9% of its three-month relative strength of 166.45 in the latest month (own arithmetic, a simple ratio rather than a return decomposition, using a 3.98% benchmark gain implied by …
The market is paying 7.9 times sales for a company that has guided growth to halve. Atlassian (NASDAQ:TEAM) reported fiscal fourth quarter revenue up 28%, cloud revenue of USD 1.213 billion up 31%, operating income of USD 211 million and free cash flow of …
The six-month leader earned most of its strength recently, which makes it the least diverged of the four. Moderna (NASDAQ:MRNA) has a three-month relative strength of 241.19 after a 3.98% benchmark gain implied by other readings, which is 88.4% of the six-month reading (own …